Literature DB >> 16306075

Ten methodological lessons from the multi-country evaluation of integrated Management of Childhood Illness.

Jennifer Bryce1, Cesar G Victora.   

Abstract

OBJECTIVE: To describe key methodological aspects of the Multi-Country Evaluation of the Integrated Management of Childhood Illness strategy (MCE-IMCI) and analyze their implications for other public health impact evaluations.
DESIGN: The MCE-IMCI evaluation designs are based on an impact model that defined expectations in the late 1990s about how IMCI would be implemented at country level and below, and the outcomes and impact it would have on child health and survival. MCE-IMCI studies include: feasibility assessments documenting IMCI implementation in 12 countries; in-depth studies using compatible designs in five countries; and cross-site analyses addressing the effectiveness of specific subsets of IMCI activities. The MCE-IMCI was designed to evaluate the impact of IMCI, and also to see that the findings from the evaluation were taken up through formal feedback sessions at national, sub-national and local levels.
RESULTS: Issues that arose early in the MCE-IMCI included: (1) defining the scope of the evaluation; (2) selecting study sites and developing research designs; (3) protecting objectivity; and (4) developing an impact model. Issues that arose mid-course included: (5) anticipating and addressing problems with external validity; (6) ensuring an appropriate time frame for the full evaluation cycle; (7) providing feedback on results to policymakers and programme implementers; and (8) modifying site-specific designs in response to early findings about the patterns and pace of programme implementation. Two critical issues could best be addressed only near the close of the evaluation: (9) factors affecting the uptake of evaluation results by policymakers and programme decision makers; and (10) the costs of the evaluation.
CONCLUSIONS: Large-scale effectiveness evaluations present challenges that have not been addressed fully in the methodological literature. Although some of these challenges are context-specific, there are important lessons from the MCE that can inform future designs. Most of the issues described here are not addressed explicitly in research reports or evaluation textbooks. Describing and analyzing these experiences is one way to promote improved impact evaluations of new global health strategies.

Entities:  

Mesh:

Year:  2005        PMID: 16306075     DOI: 10.1093/heapol/czi056

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  22 in total

1.  Addressing the implementation gap in global road safety: exploring features of an effective response and introducing a 10-country program.

Authors:  Adnan A Hyder; Katharine A Allen; Gayle Di Pietro; Claudia A Adriazola; Rochelle Sobel; Kelly Larson; Margie Peden
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Pneumonia's second wind? A case study of the global health network for childhood pneumonia.

Authors:  David Berlan
Journal:  Health Policy Plan       Date:  2015-10-05       Impact factor: 3.344

Review 3.  Child health and survival in the Eastern Mediterranean region.

Authors:  Zulfiqar A Bhutta; Asim Belgaumi; Mohammad Abdur Rab; Zein Karrar; Mohamed Khashaba; Nezha Mouane
Journal:  BMJ       Date:  2006-10-21

4.  Introduction to use of health impact metrics for programmatic decision making in global health.

Authors:  Patricia H David
Journal:  BMC Public Health       Date:  2013-06-17       Impact factor: 3.295

5.  Targeted interventions of the Avahan program and their association with intermediate outcomes among female sex workers in Maharashtra, India.

Authors:  Mandar M Mainkar; Dilip B Pardeshi; Jayesh Dale; Sucheta Deshpande; Shirin Khazi; Abhishek Gautam; Prabuddhagopal Goswami; Rajatashuvra Adhikary; Shreena Ramanathan; Bitra George; Ramesh S Paranjape
Journal:  BMC Public Health       Date:  2011-12-29       Impact factor: 3.295

6.  Assessment of the scale, coverage and outcomes of the Avahan HIV prevention program for female sex workers in Tamil Nadu, India: is there evidence of an effect?

Authors:  S Thilakavathi; K Boopathi; C P Girish Kumar; A Santhakumar; R Senthilkumar; C Eswaramurthy; V Ilaya Bharathy; L Ramakrishnan; G Thongamba; R Adhikary; R Paranjape
Journal:  BMC Public Health       Date:  2011-12-29       Impact factor: 3.295

7.  Condom use and prevalence of syphilis and HIV among female sex workers in Andhra Pradesh, India - following a large-scale HIV prevention intervention.

Authors:  Hari Kumar Rachakulla; Venkaiah Kodavalla; Hemalatha Rajkumar; S P V Prasad; Srinivasan Kallam; Prabuddhagopal Goswami; Jayesh Dale; Rajatashuvra Adhikary; Ramesh Paranjape; G N V Brahmam
Journal:  BMC Public Health       Date:  2011-12-29       Impact factor: 3.295

8.  An assessment of a large-scale HIV prevention programme for high-risk men who have sex with men and transgenders in Andhra Pradesh, India: using data from routine programme monitoring and repeated cross-sectional surveys.

Authors:  Prabuddhagopal Goswami; Hari Kumar Rachakulla; Lakshmi Ramakrishnan; Shajan Mathew; Shreena Ramanathan; Bitra George; Rajatashuvra Adhikary; Venkaiah Kodavalla; Hemalatha Rajkumar; Ramesh S Paranjape; G N V Brahmam
Journal:  BMJ Open       Date:  2013-04-08       Impact factor: 2.692

9.  Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme.

Authors:  Manuel W Hetzel; Nelly Iteba; Ahmed Makemba; Christopher Mshana; Christian Lengeler; Brigit Obrist; Alexander Schulze; Rose Nathan; Angel Dillip; Sandra Alba; Iddy Mayumana; Rashid A Khatib; Joseph D Njau; Hassan Mshinda
Journal:  Malar J       Date:  2007-06-29       Impact factor: 2.979

10.  Vouchers for scaling up insecticide-treated nets in Tanzania: methods for monitoring and evaluation of a national health system intervention.

Authors:  Kara Hanson; Rose Nathan; Tanya Marchant; Hadji Mponda; Caroline Jones; Jane Bruce; Godlove Stephen; Jo Mulligan; Hassan Mshinda; Joanna Armstrong Schellenberg
Journal:  BMC Public Health       Date:  2008-06-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.